CardioPad, Cameroonian Medical Technology Transforming Access to Heart Diagnostics Across Africa

CardioPad is a groundbreaking medical technology developed by Cameroonian engineer Arthur Zang, designed to transform access to heart diagnostics across Africa. The portable tablet device enables healthcare workers to perform electrocardiograms (ECGs) in remote areas and transmit the results via mobile networks to cardiologists for rapid interpretation.

Built specifically for low-resource environments, CardioPad addresses a critical gap where specialists are often concentrated in urban centres, making diagnosis costly and inaccessible for rural populations.

CardioPad’s innovation lies in its ability to combine mobility, affordability, and telemedicine into one solution. The device can record, analyse, and transmit cardiac data in real time, allowing patients in underserved regions to receive expert diagnosis without travelling long distances.

With reliability rates reported at nearly 98% in signal processing tests, the technology offers a credible alternative to traditional, expensive diagnostic equipment.

By reducing both time and cost barriers, CardioPad is helping to improve early detection and management of cardiovascular diseases—one of the leading health challenges across the continent.

Since its development, CardioPad has gained international attention as Africa’s first medical tablet and has been deployed in multiple countries including Cameroon, Gabon, India, and Nepal.

Zang’s innovation has earned prestigious recognition, including the 2014 Rolex Award for Enterprise and the Africa Prize for Engineering Innovation in 2016, underscoring its global impact and potential to transform healthcare delivery.

With ongoing ambitions to scale production and expand into additional medical devices through his company Himore Medical, CardioPad stands as a powerful example of African-built technology addressing local challenges with global relevance.